GrowGeneration Joins U.S. Cannabis Roundtable Amid Federal Rescheduling Push
Event summary
- GrowGeneration Corp. joined the U.S. Cannabis Roundtable on July 7, 2026.
- CEO Darren Lampert will represent the company in policy advocacy efforts.
- USCR focuses on federal cannabis reform, financial access, and industry standardization.
- Move comes as medical cannabis shifts to Schedule III under the Controlled Substances Act.
The big picture
GrowGeneration's USCR membership signals strategic alignment with federal cannabis reform efforts. The company positions itself as a key supplier in an industry poised for regulatory shifts, particularly following medical cannabis rescheduling. This move comes amid broader consolidation trends in the cannabis sector, where ancillary service providers are increasingly shaping policy frameworks.
What we're watching
- Regulatory Tailwinds
- How Schedule III rescheduling will affect GrowGeneration's customer base and tax relief opportunities.
- Industry Advocacy
- Whether USCR's collective lobbying can accelerate federal cannabis reform.
- Market Positioning
- The pace at which GrowGeneration can capitalize on its dual agriculture-cannabis expertise.